Leuprolide Mega Study
Contents
Leuprolide
Leuprolide

Related

A
Count
A
Treatments
A
Effects

Tags

Leuprolide

Treatment Effectiveness

User reported effectiveness ratings Leuprolide for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Endometriosis 14% 43% 0% 43% 0% 7

Side Effects

User-reported side effects of Leuprolide

Side Effect Percent of Reports Leuprolide
Diarrhea 38%
Acne 35%
Constipation 69%
Depression 76%
Rosacea 0%
Urinary Incontinence 17%
Absence of Menstrual Periods in Women 89%
Actually I Now Take Nuvigil Which Is the Same Medicine With Just a Variant of the Same Chemical 0%
Anxiety or Nervousness 69%
Arms and Legs Tingle and Feel Creepy Crawly 20%
Bleeding, Bruising, Burning, Pain, Pressure, Itching, Swelling, or Redness at the Place Where the Im 6%
Breast Tenderness or Change in Breast Size in Both Men and Women 44%
Change in Weight 83%
Chills Sweats on First Night 20%
Decrease in Sexual Desire in Men and Women or Ability to Perform in Men 81%
Decrease in Size of Testicles 0%
Difficulty Concentrating 76%
Difficulty Falling Asleep or Staying Asleep 75%
Difficulty With Memory 81%
Dizziness 59%
Firmness or Hardness at Subcutaneous Injection Spot 19%
Flu-Like Symptoms 47%
Hair Loss 31%
Hot Flashes (A Sudden Wave of Mild or Intense Body Heat) 95%
Improved Breathing 0%
Increase in Appetite 29%
Increased Need to Urinate, Especially at Night 53%
Intolerance/Allergy 0%
Itching, Swelling, Burning, Stinging, Pain, Bruising, Redness, or Development of a Sore at Injection 29%
Loss of Appetite 38%
Low Energy 100%
Low Levels of Energy - Always 88%
Muscle Fatigue/trembling 70%
Over-Stimulated Leading to Crash 0%
Pain in GI Tract 40%
Prozac; Hyperstimulated Causing Crash 0%
Reduced Pain 58%
Seratonin Storm 0%
Severe Stomach Pain 40%
Sores in Nose and Mouth 22%
Spotting (Light Vaginal Bleeding) 41%
Suicidal 0%
Sweating or Night Sweats 89%
Swelling of the Hands, Feet, Ankles, or Lower Legs 25%
Too Wired to Sleep 0%
Vaginal Discharge, Dryness, or Itching in Women 59%
Vomiting 24%
Weakness 75%
Wired 0%
Tiredness 94%
Headache 80%
Insomnia 20%
Nausea 71%
Muscle Aches 76%

Below is the degree of change seen after Leuprolide is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Leuprolide Info

Property Value
Variable Name Leuprolide
Aggregation Method SUM
Analysis Performed At 2020-05-04
Duration of Action 21 days
Filling Value 0
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 30 minutes
Unit Count
User Variables 0
Variable Category Treatments
Variable ID 94162